Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 157 results.
User Information
Export Records
  1. 1.   Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses
  2. Uyanik, Burhan; Goloudina, Anastasia R.; Akbarali, Aamir; Grigorash, Bogdan B.; Petukhov, Alexey V.; Singhal, Sunil; Eruslanov, Evgeniy; Chaloyard, Jeanne; Lagorgette, Lisa; Hadi, Tarik; Baidyuk, Ekaterina V.; Sakai, Hiroyasu; Tessarollo,Lino; Ryffel, Bernhard; Mazur, Sharlyn J.; Lirussi, Frederic; Garrido, Carmen; Appella, Ettore; Demidov, Oleg N.
  3. NATURE COMMUNICATIONS. 2021, Jun 15; 12(1):
  1. 2.   Polymorphic Triple beta-Sheet Structures Contribute to Amide Hydrogen/Deuterium (H/D) Exchange Protection in the Alzheimer Amyloid beta 42 Peptide
  2. Ma, B. Y.; Nussinov, R.
  3. Journal of Biological Chemistry. 2011, Sep; 286(39): 34244-34253.
  1. 3.   Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy
  2. Joshi, A.; Garg, H.; Ablan, S.; Freed, E. O.; Nagashima, K.; Manjunath, N.; Shankar, P.
  3. Virology. 2011, Jul; 415(2): 95-106.
  1. 4.   Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients
  2. Glynn, S. A.; Boersma, B. J.; Dorsey, T. H.; Yi, M.; Yfantis, H. G.; Ridnour, L. A.; Martin, D. N.; Switzer, C. H.; Hudson, R. S.; Wink, D. A.; Lee, D. H.; Stephens, R. M.; Ambs, S.
  3. Journal of Clinical Investigation. 2010, Nov; 120(11): 3843-3854.
  1. 5.   Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Molecular Recognition. 2010, Mar-Apr; 23(2): 232-240.
  1. 6.   Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation
  2. Huang, J.; Chen, K. Q.; Huang, J. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O.; Bian, X. W.; Gao, Y. Q.; Wang, J. M.
  3. Carcinogenesis. 2009 30(2): 348-355.
  1. 7.   Metallothionein protection of cadmium toxicity
  2. Klaassen, C. D.; Liu, J.; Diwan, B. A.
  3. Toxicology and Applied Pharmacology. 2009 238(3): 215-220.
  1. 8.   Crystal structures of HIV-1 nonnucleoside reverse transcriptase inhibitors: N-benzyl-4-methyl-benzimidazoles
  2. Ziolkowska, N. E.; Michejda, C. J.; Bujacz, G. D.
  3. Journal of Molecular Structure. 2009 930(1-3): 157-161.
  1. 9.   Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen
  2. Amundson, S. A.; Do, K. T.; Vinikoor, L. C.; Lee, R. A.; Koch-Paiz, C. A.; Ahn, J.; Reimers, M.; Chen, Y.; Scudiero, D. A.; Weinstein, J. N.; Trent, J. M.; Bittner, M. L.; Meltzer, P. S.; Fornace, A. J.
  3. Cancer Research. 2008 68(2): 415-424.
  1. 10.   Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect
  2. Gao, L.; Hanson, M. N.; Balakrishnan, M.; Boyer, P. L.; Roques, B. P.; Hughes, S. H.; Kim, B.; Bambara, R. A.
  3. Journal of Biological Chemistry. 2008 283(14): 9196-9205.
  1. 11.   Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: Effects on virion morphogenesis and RNA maturation
  2. Moore, M. D.; Fu, W.; Soheilian, F.; Nagashima, K.; Ptak, R. G.; Pathak, V. K.; Hu, W. S.
  3. Virology. 2008 379(1): 152-160.
  1. 12.   Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme
  2. Morningstar, M. L.; Roth, T.; Farnsworth, D. W.; Smith, M. K.; Watson, K.; Buckheit, R. W.; Das, K.; Zhang, W. Y.; Arnold, E.; Julias, J. G.; Hughes, S. H.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2007, Aug; 50(17): 4003-4015.
  1. 13.   Natural products active in aberrant c-Kit signaling
  2. Henrich, C. J.; Goncharova, E. I.; Wilson, J. A.; Gardella, R. S.; Johnson, T. R.; McMahon, J. B.; Takada, K.; Bokesch, H. R.; Gustafson, K. R.
  3. Chemical Biology & Drug Design. 2007, May; 69(5): 321-330.
  1. 14.   A second-site suppressor significantly improves the defective phenotype impolsed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein
  2. Tang, S. X.; Ablan, S.; Dueck, M.; Ayala-Lopez, W.; Soto, B.; Caplan, M.; Nagashima, K.; Hewlett, I. K.; Freed, E. O.; Levin, J. G.
  3. Virology. 2007, Mar; 359(1): 105-115.
  1. 15.   Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097
  2. Das, K.; Sarafianos, S. G.; Clark, A. D.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Journal of Molecular Biology. 2007, Jan; 365(1): 77-89.
  1. 16.   Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma
  2. Moslehi, R.; Chatterjee, N.; Church, T. R.; Chen, J.; Yeager, M.; Weissfeld, J.; Hein, D. W.; Hayes, R. B.
  3. Pharmacogenomics. 2006, Sep; 7(6): 819-829.
  1. 17.   Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator
  2. Hurt, E. M.; Thomas, S. B.; Peng, B.; Farrar, W. L.
  3. Cancer Biology & Therapy. 2006, Sep; 5(9): 1154-1160.
  1. 18.   Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses
  2. Waalkes, M. P.; Liu, J.; Kasprzak, K. S.; Diwan, B. A.
  3. International Journal of Cancer. 2006, JUL 1; 119(1): 28-32.
  1. 19.   Distribution and three-dimensional structure of AIDS virus envelope spikes
  2. Zhu, P.; Liu, J.; Bess, J.; Chertova, E.; Lifson, J. D.; Grise, H.; Ofek, G. A.; Taylor, K. A.; Roux, K. H.
  3. Nature. 2006, JUN 15; 441(7095): 847-852.
  1. 20.   Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation
  2. Nunez, N. P.; Oh, W. J.; Rozenberg, J.; Perella, C.; Anver, M.; Barrett, J. C.; Perkins, S. N.; Berrigan, D.; Moitra, J.; Varticovski, L.; Hursting, S. D.; Vinson, C.
  3. Cancer Research. 2006, MAY 15; 66(10): 5469-5476.
  1. 21.   gamma-cleavage-independent functions of presenilin, nicastrin, and aph-1 regulate cell-junction organization and prevent tau toxicity in vivo
  2. Doglio, L. E.; Kanwar, R.; Jackson, G. R.; Perez, M.; Avila, J.; Dingwal, C.; Dotti, C. G.; Fortini, M. E.; Feiguin, F.
  3. Neuron. 2006, MAY 4; 50(3): 359-375.
  1. 22.   Effects of mutations in the human immunodeficiency virus type 1 gag gene on RNA packaging and recombination
  2. Nikolaitchik, O.; Rhodes, T. D.; Ott, D.; Hu, W. S.
  3. Journal of Virology. 2006, MAY; 80(10): 4691-4697.
  1. 23.   Comparison of the human and worm p53 structures suggests a way for enhancing stability
  2. Pan, Y. P.; Ma, B. Y.; Levine, A. J.; Nussinov, R.
  3. Biochemistry. 2006, Mar; 45(12): 3925-3933.
  1. 24.   IL-3-mediated TNF production is necessary for mast cell development
  2. Wright, H. V.; Bailey, D.; Kashyap, M.; Kepley, C. L.; Drutskaya, M. S.; Nedospasov, S. A.; Ryan, J. J.
  3. Journal of Immunology. 2006, FEB 15; 176(4): 2114-2121.
  1. 25.   Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy
  2. Boguslavsky, R. L.; Stewart, C. L.; Worman, H. J.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 653-663.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel